SCHEMBL14720529

SCHEMBL14720529

COCC1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3437946 0.94 CA1 (0.49)
SCHEMBL15229446 0.84 CA1 (0.39)
SCHEMBL684715 0.83 CA1 (0.41)
SCHEMBL2730971 0.79 NPC1 (0.44)
SCHEMBL18516995 0.78
SCHEMBL16076191 0.76 CA1 (0.36)
SCHEMBL8205330 0.76 NPC1 (0.42)
SCHEMBL25160054 0.75 SMN1; SMN2 (0.43)
SCHEMBL15198303 0.75
SCHEMBL21006006 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852163-A Macrocyclic compound containing heteroatoms, and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-10-29 CN disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed